Read more
Cyclic Vomiting Syndrome and Cannabinoid Hyperemesis comprehensively reviews the clinical features and pathophysiology of cyclic vomiting syndrome (CVS) and cannabinoid hyperemesis syndrome (CHS). This book differentiates the clinical presentation of CVS and CHS from other vomiting syndromes and provides the information necessary to diagnose and effectively treat these disorders.
Compiled by expert CVS/CHS clinicians and written by physicians and researchers from several disciplines, this reference provides the most updated, evidence-based approaches, and summarizes the latest research on CVS/CHS. Important topics such as the neural systems that drive nausea and vomiting, clinical features of CVS/CHS including its subtypes, insights into pathogenesis, as well as the curious association of hot-water bathing associated with both of these disorders are all explored.
This is a must-have reference for residents and fellows in training, as well as busy clinicians who care for patients with CVS and CHS across multiple care settings including ambulatory clinics, the emergency department, hospitals, and substance use/abuse treatment centers. It is also a useful reference for investigators with an interest in these vomiting disorders.
List of contents
1. Cyclic vomiting syndrome health expereinces among patients and their caregivers
2. Central nervous system pathways of nausea and vomiting
3. Clinical features of cyclic vomiting syndrome
4. Cyclic vomiting syndrome subtypes - do they provide insight into cyclic vomiting syndrome pathogenesis
5. Clinical and pathophysiological relationship between migraines and cyclic vomiting syndrome
6. Psychosocial contributors to cyclic vomiting syndrome
7. Treatment of acute cyclic vomiting syndrome attacks
8. Prevention of recurrent cyclic vomiting syndrome episodes
9. Clinical features of cannabinoid hyperemesis syndrome
10. How common is cannabinoid hyperemesis syndrome and why is it so hard to diagnose?
11. Proposed mechanisms of cannabinoid hyperemesis syndrome - how can cannabinoid pathways both relieve and cause vomiting?
12. The curious association of hot-water bathing with cyclic vomiting and cannabinoid hyperemesis syndromes
13. Management of cannabinoid hyperemesis syndrome - is it more than just avoiding cannabis use?
14. Role of emergency department in cyclic vomiting syndrome and cannabinoid hyperemesis syndrome care
15. What can be accomplished to advance the field?
About the author
William L. Hasler, MD is a Professor of Medicine in the Division of Gastroenterology and Hepatology, at the Mayo Clinic in Scottsdale, Arizona. Dr. Hasler’s research focuses on nausea and vomiting and the pathophysiology of gastric motility disorders, and he is an internationally recognized expert in clinical and translational research in CVS and gastroparesis. He serves as a lead advisor to the Rome Foundation and has helped craft the clinical descriptions of CVS and CHS in adults. He also provided pivotal input to develop the first clinical guidelines on the management of CVS in adultsDavid J. Levinthal, MD, PhD is an Assistant Professor of Medicine in the Division of Gastroenterology, Hepatology and Nutrition at the University of Pittsburgh School of Medicine in Pittsburgh, Pennsylvania. Dr. Levinthal’s research focuses on the neural mechanisms of brain-gut interactions and autonomic function, and he is involved in clinical and translational research in CVS. He serves as a Counselor of the American Neurogastroenterology and Motility Society, a Medical Advisor of the Cyclic Vomiting Syndrome Association, and helped to develop the first clinical guidelines on the management of CVS in adults.Thangam Venkatesan, MD is Professor of Clinical Medicine in the Division of Gastroenterology, Hepatology and Nutrition at the Ohio State University in Columbus, Ohio. Patients with CVS travel across the US and beyond to access her well-established CVS center. As a leading CVS expert, she serves as the Chief Medical Advisor of the Cyclic Vomiting Syndrome Association and spearheaded the first clinical guidelines on the management of CVS in adults. She conducts clinical and translational research to develop better therapies for patients with CVS around the world.
